Lindab International AB :Lindab's Report for the Second

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 18, 2014 at 1:45 AM

Lindab International AB :Lindab's Report for the Second Quarter 2014

Second quarter 2014 * Sales revenue increased by 7 percent to SEK 1,757 m (1,643), an increase of 4 percent when adjusted for currency and structure. * Operating profit (EBIT) amounted to SEK 125 m (132), excluding one-off items of SEK -1 m (-6). * The operating margin (EBIT), excluding one-off items, amounted to 7.1 percent (8.0). * The after-tax result increased to SEK 82 m (61). * Earnings per share increased to SEK 1.07 (0.80). * Cash flow from operating activities improved to SEK 88 m (26). * The net debt / equity ratio amounted to 0.6 (0.8) at the end of the quarter. January - June 2014 * Sales revenue increased by 9 percent to SEK 3,263 m (2,984), an increase of 7 percent when adjusted for currency and structure. * Operating profit (EBIT) increased to SEK 185 m (145), excluding one-off items of SEK -4 m (-12). * The operating margin (EBIT), excluding one-off items, increased to 5.7 percent (4.9). * The after-tax result increased to SEK 96 m (33). * Earnings per share increased to SEK 1.26 (0.43). * Cash flow from operating activities amounted to SEK -138 m (29). Lindab's President and CEO, Anders Berg, commented: The sales growth of recent quarters has continued. The main part of our activities, Products & Solutions, is showing good sales growth in all regions and we are continuing to increase availability through new establishments in e.g. Nantes, Paris, Bratislava and Moscow, upgrading of branches, notably in Sweden and Romania, as well as a broadened product range. With an organic growth for this segment of eight percent, together with an improved operating margin, we see that the activities and plans we have started up are already generating results. Unfortunately, our concern about an increasing slowdown in Russia and Belarus, which we had at the end of the first quarter, has been confirmed. This slowdown started already during the second half of 2013, and has been exacerbated by the increased political unrest in the region. This is affecting our Building Systems segment, which has significant exposure to these markets. Despite the fact that needs and demand exist, customers are choosing to postpone capital-intensive decisions into the future. This is the single largest reason for the deterioration in earnings in the quarter for both the division and the Group. We expect that there will be a continued cautious trend in these markets during the autumn. The after-tax result improved significantly in the quarter as a result of the new lower financing costs. The implementation of the new organisation which was launched in autumn 2013 has also generated the anticipated effects, and we are now working further on utilising the strength of our offering on the local markets. As an example, there have been successful initiatives to sell rainwater systems on what were previously deemed typical "ventilation markets" in Western Europe. Small steps, but clearly in the right direction. End The information here is that which Lindab International AB has willingly chosen to make public or that which it is obliged to make public according to the Swedish Securities Market Act and/or the Financial Instruments Trading Act. Contacts: LINDAB Anders Berg, CEO Email: anders.berg@lindab.com Mobile: +46 (0) 70 35 89155 Per Nilsson, CFO Email: per.nilsson@lindab.com Mobile: +46 (0)70 33 85069 Lindab - A Ventilation and Building Products company: Lindab develops, manufactures, markets and distributes products and system solutions for simplified construction and improved indoor climate. The products are characterised by their high quality, ease of assembly, energy efficiency, consideration towards the environment, and are delivered with high levels of service. Altogether, this increases customer value. The Group had sales revenue of SEK 6,523 m in 2013 and is established in 32 countries with approximately 4,400 employees. The main market is non-residential construction, which accounts for 80 percent of sales, while residential accounts for 20 percent of sales.During 2013, the Nordic market accounted for 46 percent, the CEE/CIS (Central and Eastern Europe plus other former Soviet states) for 24 percent, Western Europe for 27 percent and other markets for 3 percent of total sales. The share is listed on the Nasdaq OMX Nordic Exchange, Stockholm, Mid Cap. For more information visit www.lindabgroup.com [HUG#1829172]

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

IDEAYA's IDE101: A New Front in Cancer Battle

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Princess Cruises Launches New Era at Celebration Key

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Beef 'O' Brady's Expands Into Tuscaloosa Market

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

CVS Study: GLP-1 Drugs Effective But Costly

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...